Company / Book Value per Share
ANI Pharmaceuticals, Inc. Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$25.617
FY2025
5-year range
$19.292 / $26.508
FY2021-FY2025
Trend
+3.2%
vs FY2024
Sector context
#19 of 209
Health Care
What the data says
Among 209 Health Care companies, ANI Pharmaceuticals, Inc. is in the top 9% for book value per share. Book Value per Share has increased for 3 consecutive years, from $19.292 in FY2022 to $25.617 in FY2025.
Based on SEC 10-K filings.
$25.617 in FY2025 with a 5-year CAGR of +9.4%. Top quartile in the Health Care sector.
Improved from $23.785 to $25.617 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- +9.9%
- 5-Year CAGR
- +9.4%
- 10-Year CAGR
- -
Sector benchmark
-86.5% below sector average
Key checks
Key Insights
- ANI Pharmaceuticals, Inc.'s book value per share has grown for 3 consecutive years.
- 5-year CAGR of +9.4%, indicating consistent growth.
- In FY2025, book value per share increased 3.2% year-over-year.
- Ranks #19 out of 209 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $25.617 | +3.2% |
| FY2024 | $24.827 | +4.4% |
| FY2023 | $23.785 | +23.3% |
| FY2022 | $19.292 | -27.2% |
| FY2021 | $26.508 | +62.1% |
| FY2020 | $16.357 | -11.2% |
| FY2019 | $18.428 | +10.0% |
| FY2018 | $16.757 | +10.8% |
| FY2017 | $15.121 | +3.2% |
| FY2016 | $14.659 | -99.8% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026